Impact of SMTP Targeting Plasminogen and Soluble Epoxide Hydrolase on Thrombolysis, Inflammation, and Ischemic Stroke

Area of Science:

• Biochemistry
• Pharmacology
• Mycology

Background:

• Stachybotrys microspora triprenyl phenols (SMTP) are fungal-derived small molecules.
• SMTP modulate plasminogen, enhancing fibrinolysis.
• Some SMTP congeners possess anti-inflammatory properties via soluble epoxide hydrolase inhibition.

Purpose of the Study:

• To review the discovery, mechanism of action, and pharmacological activities of SMTP.
• To highlight the therapeutic potential of SMTP in ischemic stroke.
• To discuss the development of SMTP as a novel therapeutic agent.

Main Methods:

• Literature review of studies on SMTP.
• Analysis of SMTP's mechanism in plasminogen modulation and fibrinolysis.
• Evaluation of anti-inflammatory effects and therapeutic efficacy in preclinical models.

Main Results:

• SMTP enhance fibrinolysis by altering plasminogen conformation and increasing fibrin binding.
• SMTP congeners demonstrate anti-inflammatory effects.
• SMTP ameliorate ischemic stroke in animal models, notably suppressing hemorrhagic transformation.
• SMTP show potential as a first-in-class agent promoting thrombolysis while preventing bleeding.

Conclusions:

• SMTP possess a unique dual mechanism of action, promoting thrombolysis and suppressing bleeding.
• SMTP represent a promising therapeutic strategy for ischemic stroke.
• Clinical development of an SMTP congener is underway, indicating significant therapeutic potential.